South America Virus-like Particles Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Hepatitis, Cancer/HPV, and Gaucher disease), Source (Yeast, Insect Cell, Plant, and Others), and Application (Vaccines and Therapeutics)

TIPRE00026835 | Pages: 104 | Pharmaceuticals | Jan 2022 | Type: Regional | Status: Published

Market Introduction

Major countries included as a part of analysis for South America includes Argentina, Brazil, and Rest of South America. The growth of the market for the virus-like particles in the region is attributed to the aging population, flourishing diagnostics market and growing initiatives of the major players in the pharmaceutical industry. The market is likely to propel in the forecasted period owing to the recent technological developments which have made a direct impact on the economy of Brazil that has advanced to a large extent. About 100,000 cases of acute hepatitis B virus (HBV) infection occur annually in South America. The overall prevalence of hepatitis B (HBV) infection in low risk populations ranges from 6.7% to 41%, while hepatitis B surface antigen (HBsAg) rates range from 0.4% to 13%. In high endemicity aboriginal or rural populations, perinatal transmission may play a major part in the spread of hepatitis B (HBV).

As South America becomes the new epicenter of COVID-19, fears are growing about depending on a vaccine designed and manufactured overseas, especially since wealthier countries have historically had better access to immunizations. Governments in South America acted quickly and preemptively to safeguard their citizens and control the spread of COVID-19 across the area, as well as its economic consequences.  According to reports, certain governments in high-income countries have attempted to purchase vaccine-manufacturing companies or a portion of their supply. According to the researchers, they coat virus-like particles with pieces of the proteins that the coronavirus utilizes to enter human cells in the hopes of tricking the immune system into creating antibodies that will block the coronavirus during infection. Because these particles can't replicate inside the human body, and the virus-like particles regarded safer than vaccinations created from weakened viruses, and the technology has already been utilized to develop commercially accessible hepatitis B and human papillomavirus vaccines. Further, Argentina and Mexico inked an agreement with mAbxience, the British pharmaceutical company AstraZeneca, and Oxford University in August 2020. The goal is to create between 150 and 250 million doses of the COVID-19 vaccine, which will be distributed throughout South America is expected to help the region in its fight against the COVID-19.

 


Get more information on this report :



Market Overview and Dynamics

The virus-like particles market in South America is expected to grow from US$ 199.78 million in 2021 to US$ 324.57 million by 2028; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028. Vaccines form one of the significant segments of the pharmaceuticals industry. They have an extensive application in the immunization of humans and animals against common infections. Companies operating in the pharmaceuticals and biopharmaceuticals markets continuously focus on product innovations and developments to sustain competition in the market. For instance, the market players have been significantly investing in the development of vaccines against COVID-19 and studies related to VLP. The active developments by life sciences companies, coupled with government support for the same, is contributing to the VLP market growth.

Key Market Segments

In terms of product type, the hepatitis segment accounted for the largest share of the South America virus-like particles market in 2021. In terms of source, the yeast segment accounted for the largest share of the South America virus-like particles market in 2021. In term of application, vaccines segment held a larger market share of the virus-like particles market in 2021.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the virus-like particles market in South America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Merck & Co., Inc.; GlaxoSmithKline plc.; Pfizer Inc.; Sanofi; Serum Institute of India Pvt. Ltd.; BHARAT BIOTECH; and LG Chem among others.

Reasons to buy report

  • To understand the South America virus-like particles market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for South America virus-like particles market
  • Efficiently plan M&A and partnership deals in South America virus-like particles market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form South America virus-like particles market
  • Obtain market revenue forecast for market by various segments from 2021-2028 in South America region.

South America Virus-like Particles Market Segmentation

 

South America Virus-like Particles Market – By Product type

  • Hepatitis
  • Cancer/HPV
  • Gaucher Disease

South America Virus-like Particles Market – By Source

  • Yeast
  • Insect Cell
  • Plant
  • Others

South America Virus-like Particles Market – By Application

  • Vaccines
  • Therapeutics

South America Virus-like Particles Market – By Country

  • Brazil
  • Argentina
  • Rest of SAM     

South America Virus-like Particles Market – Companies Mentioned

  • Merck & Co., Inc.                                                       
  • GlaxoSmithKline plc.
  • Pfizer Inc.                                                                    
  • Sanofi                                                                          
  • Serum Institute of India Pvt. Ltd.                            
  • BHARAT BIOTECH                                                       
LG Chem                                                  

1.          Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South America Virus-like Particles Market – By Product Type

1.3.2        South America Virus-like Particles Market – By Source

1.3.3        South America Virus-like Particles Market – By Application

1.3.4        South America Virus-like Particles Market – By Country

2.           South America Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South America Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           South America Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Up-raising Prevalence of Infectious Viral Diseases

5.1.2        Surging Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Availableness of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Scaling Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Consistent Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           South America Virus-like Particles Market Analysis

6.1         South America Virus-like Particles Market Revenue Forecast and Analysis

7.           South America Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         South America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           South America Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         South America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           South America Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         South America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        South America Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     South America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1       Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.1.3       Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.4       Brazil Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)

10.1.1.1.5       Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.2.3       Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       Argentina: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)

10.1.1.2.5       Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       Rest of South America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       Rest of South America: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Million)

10.1.1.3.5       Rest of South America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on South America Virus-like Particles Market

11.1      Impact Assessment of COVID-19 Pandemic

12.        South America Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sanofi

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Serum Institute of India Pvt. Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      BHARAT BIOTECH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      LG Chem

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             South America Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

Table 3.             Brazil Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5.             Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

Table 6.             Argentina: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 7.             Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             Rest of South America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)

Table 9.             Rest of South America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10.          Rest of South America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11.          Organic Developments Done by Companies

Table 12.          Inorganic Developments Done by Companies

Table 13.          Glossary of Terms: Virus-like Particles Market

 


LIST OF FIGURES

Figure 1.           South America Virus-like particles Market Segmentation

Figure 2.           South America Virus-like particles Market Segmentation, By Country

Figure 3.           South America Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in South America Virus-like particles Market

Figure 5.           Brazil to Show Significant Growth during Forecast Period

Figure 6.           South America Virus-like Particles Market, Industry Landscape

Figure 7.           South America PEST Analysis

Figure 8.           South America Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           South America Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        South America Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        South America Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        South America Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        South America Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 23.        South America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24.        Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        Rest of South America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Impact Of COVID-19 Pandemic in South America Country Markets

  1. Merck & Co., Inc.                                                       
  2. GlaxoSmithKline plc.                                                
  3. Pfizer Inc.                                                                    
  4. Sanofi                                                                         
  5. Serum Institute of India Pvt. Ltd.                           
  6. BHARAT BIOTECH                                                      
  7. LG Chem                                                                     
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South America virus-like particles market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South America virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South America market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000